P57 regulates T-cell development and prevents lymphomagenesis by balancing p53 activity and pre-TCR signaling

Blood

Volumn 123, Issue 22, 2014, Pages 3429-3439

  Matsumoto, Akinobu ^b   Takeishi, Shoichiro ^b   Nakayama, Keiichi I ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; PROTEIN P53; T LYMPHOCYTE RECEPTOR;

AGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SPECIFICITY; CONTROLLED STUDY; DEVELOPMENT; FEMALE; HEMATOLOGIC MALIGNANCY; LATENT PERIOD; LYMPHOMAGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS LYMPHOMA;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P57; E2F1 TRANSCRIPTION FACTOR; FEMALE; HETEROZYGOTE; LYMPHOMA; MICE; MICE, KNOCKOUT; PHENOTYPE; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901705216     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-10-532390     Document Type: Article

References (30)

1. Hosoya T, Maillard I, Engel JD. From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev. 2010;238(1):110-125.
2. Naito T, Tanaka H, Naoe Y, Taniuchi I. Transcriptional control of T-cell development. Int Immunol. 2011;23(11):661-668.
3. Jameson SC, Bevan MJ. T-cell selection. Curr Opin Immunol. 1998;10(2):214-219. (Pubitemid 28195753)
4. Haks MC, Krimpenfort P, van den Brakel JH, Kruisbeek AM. Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity. 1999;11(1):91-101. (Pubitemid 29359960)
5. Jiang D, Lenardo MJ, Zúñiga-Pfl ücker JC. p53 prevents maturation to the CD41CD81 stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J Exp Med. 1996;183(4): 1923-1928. (Pubitemid 26134334)
6. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT, Danska JS. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 1996;10(16):2038-2054. (Pubitemid 26346112)
7. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004;18(22):2699-2711. (Pubitemid 39507762)
8. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer. 2008;8(9):671-682.
9. Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer. 2009;9(10): 738-748.
10. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A. 1997;94(14):7245-7250. (Pubitemid 27345300)
11. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol. 1995;69(4):2491-2500.
12. Phillips AC, Bates S, Ryan KM, Helin K, Vousden KH. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 1997; 11(14):1853-1863. (Pubitemid 27315214)
13. Qin XQ, Livingston DM, Kaelin WG Jr, Adams PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A. 1994;91(23): 10918-10922. (Pubitemid 24349596)
14. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13(12):1501-1512. (Pubitemid 29297917)
15. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995;82(4):675-684.
16. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996;85(5): 707-720.
17. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1- deficient mice. Cell. 1996;85(5):733-744.
18. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclindependent kinase inhibitor function of p27Kip1. Cell. 1996;85(5):721-732.
19. Takahashi K, Nakayama K, Nakayama KI. Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. J Biochem. 2000;127(1):73-83. (Pubitemid 30094096)
20. Zhang P, Liégeois NJ, Wong C, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 1997;387(6629):151-158. (Pubitemid 27209424)
21. Matsumoto A, Takeishi S, Kanie T, et al. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell. 2011; 9(3):262-271.
22. Wolfer A, Bakker T, Wilson A, et al. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol. 2001;2(3):235-241. (Pubitemid 33706000)
23. Wolfer A, Wilson A, Nemir M, MacDonald HR, Radtke F. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. Immunity. 2002;16(6):869-879. (Pubitemid 34786485)
24. Matsuoka S, Edwards MC, Bai C, et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995;9(6):650-662.
25. Laurent J, Bosco N, Marche PN, Ceredig R. New insights into the proliferation and differentiation of early mouse thymocytes. Int Immunol. 2004; 16(8):1069-1080. (Pubitemid 39136724)
26. Cao Q, Xia Y, Azadniv M, Crispe IN. The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells. J Immunol. 2004;173(2):1111-1117. (Pubitemid 38924286)
27. Pant V, Quintás-Cardama A, Lozano G. The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans. Blood. 2012; 120(26):5118-5127.
28. DeGregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta. 2002;1602(2): 131-150.
29. Berkovich E, Ginsberg D. ATM is a target for positive regulation by E2F-1. Oncogene. 2003; 22(2):161-167. (Pubitemid 36174173)
30. Fogal V, Kartasheva NN, Trigiante G, et al. ASPP1 and ASPP2 are new transcriptional targets of E2F. Cell Death Differ. 2005;12(4): 369-376. (Pubitemid 40520688)